PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 27(Supplement_2): 205-209
2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García–López, E.
Right arrow Articles by Stenvinkel, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by García–López, E.
Right arrow Articles by Stenvinkel, P.

Part 6: Cardiovascular Complications in PD

RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS

Elvia García–López, Juan J. Carrero, Mohamed E. Suliman, Bengt Lindholm and Peter Stenvinkel

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

Correspondence to: P. Stenvinkel, Department of Renal Medicine, K56, Karolinska University Hospital at Huddinge, Stockholm 14186 Sweden. peter.stenvinkel{at}ki.se

Patients on peritoneal dialysis (PD) are at high cardiovascular risk. Although some risk factors are unmodifiable (for example, age, sex, genetics), others are exacerbated in the unfriendly uremic milieu (inflammation, oxidative stress, mineral disturbances) or contribute per se to kidney disease and cardiovascular progression (diabetes mellitus, hypertension). Moreover, several factors associated with PD therapy may both increase (by altered lipid profile, hyperinsulinemia, and formation of advanced glycation end-products) and decrease (by better blood pressure control and anemia management) cardiovascular risk. The present review discusses recent findings and therapy trends in cardiovascular research on the PD population, with emphasis on the roles of inflammation, insulin resistance, homocysteinemia, dyslipidemia, vascular calcification, and genetics/epigenetics.

KEY WORDS: Cardiovascular disease; inflammation; vascular calcification; homocysteine.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
H. Y. Choi, J. E. Lee, S. H. Han, T. H. Yoo, B. S. Kim, H. C. Park, S.-W. Kang, K. H. Choi, S. K. Ha, H. Y. Lee, et al.
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients
Nephrol. Dial. Transplant., November 19, 2009; (2009) gfp598v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. S. Aroeira, E. Lara-Pezzi, J. Loureiro, A. Aguilera, M. Ramirez-Huesca, G. Gonzalez-Mateo, M. L. Perez-Lozano, P. Albar-Vizcaino, M-A. Bajo, G. del Peso, et al.
Cyclooxygenase-2 Mediates Dialysate-Induced Alterations of the Peritoneal Membrane
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 582 - 592.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.